Abstract

Fentanyl 50-mg/mL in 0.9% Sodium Chloride Solution

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2007 - Hormone Replacement Therapy

Page(s): 328

Download in electronic PDF format for $75

Abstract

A formulation for preparing Fentanyl 50-mg/mL in 0.9% Sodium Chloride Solution. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jul/Aug 2007 Pg. 328	Fentanyl 50-mg/mL in 0.9% Sodium Chloride Solution Author(s): Allen Loyd V Jr
Jul/Aug 2007 Pg. 335	Sufentanil 50-mg/mL in 0.9% Sodium Chloride Solution Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 182-192	Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
Mar/Apr 2010 Pg. 160-164	Chemical Stability of Hydromorphone Hydrochloride in Patient-Controlled Analgesia Injector Author(s): Khondkar Dristi, Chopra Poonam, McArter John P, Rosen Joseph A, Li S Kevin
Jan/Feb 2006 Pg. 69-73	Stability of Morphine Sulfate in Polypropylene Infusion Bags for Use in Patient-Controlled Analgesia Pumps for Postoperative Pain Management Author(s): Nguyen-Xuan Tho, Griffiths William, Kern Christian, Van Gessel Elisabeth, Bonnabry Pascal
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
Nov/Dec 2007 Pg. 514-519	Topical Pain Relief: Assessment of Patient Satisfaction with a Novel Compound Containing at Least Ketoprofen Author(s): Zugerman Jessie Jean M, Reed Thomas C
Sep/Oct 2008 Pg. 463-466	Chemical Stability of Admixtures Combining Ziconotide with Fentanyl or Sufentanil During Simulated Intrathecal Administration Author(s): Shields David E, Aclan Jennifer, Szatkowski Aaron
Jul/Aug 2014 Pg. 278-286	Compounded Pain Formulations: What is the Evidence? Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Mar/Apr 2024 Pg. 100-109	Compounded Pain Formulations: What is the Evidence? Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
May/Jun 2010 Pg. 200-203	Topical Medications for Orofacial Neuropathic Pain Author(s): Bramwell Bethany L
Sep/Oct 2017 Pg. 411	Fentanyl Citrate 50-mcg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 482-483	Chemical Stability of Fentanyl in Polypropylene Syringes and Polyvinylchloride Bags Author(s): Donnelly Ronald F
Nov/Dec 2002 Pg. 456	Morphine Sulfate 2-mg/mL and Droperidol 0.08-mg/mL Injection for Patient-Controlled Analgesia Author(s): Allen Loyd V Jr
Nov/Dec 2004 Pg. 462-465	Basics of Compounding for Cough Author(s): Allen Loyd V Jr
Nov/Dec 2002 Pg. 454	Hydromorphone HCl 0.1-mg/mL Injection for Patient-Controlled Analgesia Author(s): Allen Loyd V Jr
Jul/Aug 2015 Pg. 295-300	Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
Mar/Apr 2024 Pg. 111-116	Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
Jul/Aug 2000 Pg. 253-254	Ketamine for Pain in Hospice Patients Author(s): Wood Robert M
Nov/Dec 2016 Pg. 517-520	Topical Ketamine 10% for Neuropathic Pain in Spinal Cord Injury Patients: An Open-Label Trial Author(s): Rabi Joseph, Minori Joshua, Abad Hasan, Lee Ray, Gittler Michelle